Atrial fibrillation Trials in Groningen, Netherlands
Conditions / Atrial fibrillation / Groningen, Netherlands
Clinical trials for Atrial fibrillation investigate a range of treatment strategies and patient populations.
36 total trials for this combination
Showing top 10 of 36 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02943785 | Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) | COMPLETED | PHASE3 |
| NCT00262600 | Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate | COMPLETED | PHASE3 |
| NCT03968393 | Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress | RECRUITING | PHASE4 |
| NCT00808067 | RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial | COMPLETED | PHASE3 |
| NCT02164864 | Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) | COMPLETED | PHASE3 |
| NCT03909386 | Non-interventional Study on Patients With Atrial Fibrillation and Cancer | COMPLETED | — |
| NCT07217067 | A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation | RECRUITING | — |
| NCT00403767 | An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT05643573 | A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke | TERMINATED | PHASE3 |
| NCT03505801 | Confirm Rx Insertable Cardiac Monitor SMART Registry | ACTIVE_NOT_RECRUITING | — |